EUVIMEDEUVIMED entdecken
Crossref

Surgical margin status and role of adjuvant therapy in human papillomavirus‐positive oropharyngeal cancer

Young Min Park iD, Jae-Yol Lim, Yoon Woo Koh, Eun Chang Choi, Se-Heon Kim iD

Head & Neck · 2023

DOI: 10.1002/hed.27473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2023. Verfasst von Young Min Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Papillomavirus Infections, Oropharyngeal Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We analyzed the difference in treatment results according to safety margin range and studied the role of adjuvant therapy in patients with human papillomavirus‐positive (HPV+) oropharyngeal squamous cell carcinoma (OPSCC). Materials and methods A total of 279 patients with HPV+ OPSCC were included in this study.

Results

Surgical margin and T classification were significant prognostic factors related to death. The difference in locoregional recurrence was analyzed by dividing the safety margin into groups of 5 mm. There was no significant difference in local‐regional recurrence for T1–T2 lesions between the three groups. Adjuvant therapy can significantly reduce disease recurrence in HPV+ OPSCC patients with risk factors.

Conclusions

In T1–T2 lesions without other risk factors, even with a safety margin ≥1 mm, adjuvant therapy can potentially be omitted. Adjuvant therapy can significantly reduce disease recurrence in HPV+ OPSCC patients with risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellPapillomavirus InfectionsOropharyngeal NeoplasmsHead and Neck NeoplasmsHumansHuman Papillomavirus VirusesMargins of ExcisionNeoplasm Recurrence, LocalSquamous Cell Carcinoma of Head and NeckPrognosisPapillomaviridaeRetrospective Studies

Stichwörter der Autor:innen

HPV-positive oropharyngeal canceradjuvant therapyneoadjuvant chemotherapysafety margin

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea.
  • Department of Otorhinolaryngology, Yonsei University College of Medicine, Seoul, South Korea.
  • Department of Otorhinolaryngology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, South Korea.

ORCID-Profile: Young Min Park, Se-Heon Kim

Zitieren

APA

Park, Y. M., Lim, J. Y., Koh, Y. W., Choi, E. C., & Kim, S. H. (2023). Surgical margin status and role of adjuvant therapy in human papillomavirus‐positive oropharyngeal cancer. Head & Neck. https://doi.org/10.1002/hed.27473

Vancouver

Park YM, Lim JY, Koh YW, Choi EC, Kim SH. Surgical margin status and role of adjuvant therapy in human papillomavirus‐positive oropharyngeal cancer. Head & Neck. 2023. doi:10.1002/hed.27473

BibTeX
@article{Park2023,
  author = {Park, Young Min and Lim, Jae-Yol and Koh, Yoon Woo and Choi, Eun Chang and Kim, Se-Heon},
  title = {Surgical margin status and role of adjuvant therapy in human papillomavirus‐positive oropharyngeal cancer},
  journal = {Head & Neck},
  year = {2023},
  doi = {10.1002/hed.27473}
}
Kostenlos starten →